Table 3.
Literature review of the outcome studies regarding FVFG and the MT
| Author | Year | Cases, n | Mean defect size, cm (range) | Mean time to union, months (range) | Reported union, n (%) | Mean follow up, months (range) | Complications, n (%) |
|---|---|---|---|---|---|---|---|
| FVFG | |||||||
| Dell [45] | 1984 | 4 | N/A | N/A | 3 (75%) | N/A | 0 |
| Olekas [46] | 1991 | 15 | 9.3 (5–12) | N/A | 11 (73.3%) | 23.5 (7–60) | 4 (26.7%) |
| Jupiter [47] | 1997 | 9 | 7.9 (4.5–11) | N/A | 8 (88.9%) | 24 | 3 (33.3%) |
| Adani [31] | 2004 | 12 | 8.5 (6–13) | 4.8 (2.5–8) | 11 (91.6%) | N/A (10–93) | 3 (25%) |
| Safoury [48] | 2005 | 18 | N/A | 4 (N/A) | 17 (94.4%) | N/A | N/A |
| Cano-Luís [6] | 2018 | 14 | N/A (6–11) | 4.3 (2.5–7) | 13 (92.9%) | 166.8 (96–276) | 4 (28.58%) |
| MT | |||||||
| Luo [41] | 2017 | 7 | 5.6 (4–8) | N/A | 7 (100%) | 86.7 (41–150) | 4 (57.14%) |
| Dhar [49] | 2019 | 12 | 5 (3.5–7) | 7.8 (6–12) | 12 (100%) | N/A | 0 |
| Walker [42] | 2019 | 9 | 3.9 (1.7–5.4) | 4.7 (3–12) | 9 (100%) | 4.7 (3–12) | 1 (11.11%) |
| Bourgeois [50] | 2020 | 6 | 6.4 (4.8–11.0) | 4 (2.3–6.3) | 5 (83.3%) | 103.4 (67.4–144.3) | 3 (50%) |
| Commeil [11] | 2021 | 10 | 4.3 (2–8) | 9.2 (4–13) | 9 (90%) | 50.3 (14–74) | 1 (10%) |
| Lauthe [51] | 2021 | 13 | 4 (0–12) | 5 (3–8) | 12 (92.3%) | 30 | 2 (15.38%) |
FVFG free vascularized fibular grafts, MT Masquelet technique